Peter Junker

6.4k citations
183 papers · 4.1k · h-index 35

Impact in

  • Rheumatology top 0.2%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
    • Spondyloarthritis Studies and Treatments
  • Immunology top 2%
    • T-cell and B-cell Immunology
    • Complement system in diseases
    • Immune Cell Function and Interaction

Papers in

  • Rheumatology 87
    • Rheumatoid Arthritis Research and Therapies 47
    • Systemic Lupus Erythematosus Research 27
    • Spondyloarthritis Studies and Treatments 9
  • Immunology 33
    • Galectins and Cancer Biology 9
Co-authors
Anne Voss (17 shared papers)Anders Jørgen Svendsen (26 shared papers)Mikkel Østergaard (57 shared papers)Merete Lund Hetland (60 shared papers)Kim Hørslev‐Petersen (45 shared papers)Hanne Lindegaard (35 shared papers)Kristian Stengaard‐Pedersen (41 shared papers)Helle Laustrup (8 shared papers)
Journals
Annals of the Rheumatic Diseases (19 papers)Scandinavian Journal of Rheumatology (19 papers)Arthritis Research & Therapy (7 papers)Lupus (7 papers)The Journal of Rheumatology (6 papers)
Partner nations
DenmarkUnited StatesSweden

In The Last Decade

Peter Junker

177 papers receiving 4.0k citations

Peers

Peter Junker
Comparison fields: 5 of 127
  • Rheumatology 1.8k
  • Immunology 1.1k
  • Hematology 417
  • Genetics 252
  • Immunology and Allergy 130
Replace Thomas Barnetche with:
Thomas Barnetche France
Carrie Wagner United States
Shigeto Tohma Japan
John J. Cush United States
Dae‐Hyun Yoo South Korea
L B van de Putte Netherlands
Koichiro Ohmura Japan
Gurtej S. Cheema United States
Gabriella Lakos Hungary
Corinne Miceli‐Richard France
Peter Junker relative to Thomas Barnetche France Thomas Barnetche's profile →
Citations per field
00.5×1.5×
Thomas Barnetche · 1×
Citations per year

Countries citing papers authored by Peter Junker

Since Specialization
Citations

This map shows the geographic impact of Peter Junker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Junker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Junker more than expected).

Fields of papers citing papers by Peter Junker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Junker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Junker. The network helps show where Peter Junker may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Junker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Junker Line = papers co-authored together Peter Junker links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients
Genes and Immunity ·Peter Garred, Anne Voss, HO Madsen, Peter Junker
2001154
2
Radiographic progression and remission rates in early rheumatoid arthritis – MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial
Annals of the Rheumatic Diseases ·Merete Lund Hetland, K. Stengaard‐Pedersen, Peter Junker, Mikkel Østergaard, B Ejbjerg, Søren Jacobsen, Tine Lottenburger, I. Hansen, Ulrik Tarp, (unknown), Anders Jørgen Svendsen, U. Birk Lauridsen, Torkell Ellingsen, Hanne Lindegaard, Jan Pødenphant, (unknown), Anne Grethe Jurik, Kim Hørslev‐Petersen
2010152
3
Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: An investigator‐initiated, multicenter, randomized, double‐blind, parallel‐group, placebo‐controlled study
Arthritis & Rheumatism ·Merete Lund Hetland, Kristian Stengaard‐Pedersen, Peter Junker, Tine Lottenburger, Torkell Ellingsen, Lis Smedegaard Andersen, Ib Tønder Hansen, Henrik Skjødt, (unknown), Ulrik Birk Lauridsen, Anders Jørgen Svendsen, Ulrik Tarp, Jan Pødenphant, G. Hansen, Hanne Lindegaard, Anselmo de Carvalho, Mikkel Østergaard, Kim Hørslev‐Petersen
2006133
4
A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets
Clinical Rheumatology ·Søren Jacobsen, Jørgen Holm Petersen, Susanne Ullman, Peter Junker, Anne Voss, Jesper Rasmussen, Ulrik Tarp, Lone Hvitfeldt Poulsen, G. Hansen, B. Skaarup, T M Hansen, Jan Pødenphant, P Halberg
1998122
5
YKL‐40, a Matrix Protein of Specific Granules in Neutrophils, Is Elevated in Serum of Patients with Community‐Acquired Pneumonia Requiring Hospitalization
The Journal of Infectious Diseases ·Claudia Maria Nordenbæk, Julia S. Johansen, Peter Junker, Niels Borregaard, Ole E. Sørensen, Paul A. Price
1999109
6
HLA‐G genotype and HLA‐G expression in systemic lupus erythematosus: HLA‐G as a putative susceptibility gene in systemic lupus erythematosus
Tissue Antigens ·Roberta Rizzo, Thomas Vauvert F. Hviid, Marcello Govoni, Melissa Padovan, Michele Rubini, Loredana Melchiorri, Marina Stignani, S. Carturan, M. T. Grappa, Maria Fotinidi, Stefano Ferretti, Anne Voss, Helle Laustrup, Peter Junker, Francesco Trotta, Olavio R. Baricordi
2008108
7
Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia
Clinical Immunology ·Rikke Leth‐Larsen, Claudia Maria Nordenbæk, Ida Tornøe, Vivi Moeller, Anders Schlosser, Claus Koch, B. Teisner, Peter Junker, Uffe Holmskov
2003100
8
Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study
Annals of the Rheumatic Diseases ·Merete Lund Hetland, K. Stengaard‐Pedersen, Peter Junker, Tine Lottenburger, I. Hansen, Lis Smedegaard Andersen, Ulrik Tarp, Anders Jørgen Svendsen, (unknown), U. Birk Lauridsen, Torkell Ellingsen, G. Hansen, Hanne Lindegaard, A Vestergaard, Anne Grethe Jurik, (unknown), (unknown)
200789
9
A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value
Clinical Rheumatology ·Søren Jacobsen, Jørgen Holm Petersen, Susanne Ullman, Peter Junker, Anne Voss, Jesper Rasmussen, Ulrik Tarp, Lone Hvitfeldt Poulsen, G. Hansen, B. Skaarup, T M Hansen, Jan Pødenphant, P Halberg
199888
10
Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus
Arthritis & Rheumatism ·Sergey V. Kozyrev, Susanna Lewén, Prasad M. V. Linga Reddy, Bernardo A. Pons‐Estel, (unknown), Torsten Witte, (unknown), Peter Junker, Helle Laustrup, Carmen Gutiérrez, Ana Suárez, M.F. González‐Escribano, Javier Martı́n, (unknown), Marta E. Alarcón‐Riquelme
200785
11
Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation
Scandinavian Journal of Rheumatology ·Ole Birger Pedersen, Anders Jørgen Svendsen, L. Ejstrup, Axel Skytthe, Jeffrey R. Harris, Peter Junker
200876
12
Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population.
PubMed ·Anders Jørgen Svendsen, Niels V. Holm, Kirsten Ohm Kyvik, Per Hyltoft Petersen, Peter Junker
200276
13
Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE)
Clinical & Experimental Immunology ·Hanne Vibeke Marquart, Anders Jørgen Svendsen, (unknown), Claus Henrik Nielsen, Peter Junker, S.‐E. SVEHAG, R. G. Q. Leslie
199568
14
CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic `window of opportunity'
Arthritis Research & Therapy ·Stinne Ravn Greisen, Karen Kræmmer Schelde, Tue Kruse Rasmussen, Tue Wenzel Kragstrup, Kristian Stengaard‐Pedersen, Merete Lund Hetland, Kim Hørslev‐Petersen, Peter Junker, Mikkel Østergaard, Bent Deleuran, Malene Hvid
201467
15
On the Origin of Rheumatoid Arthritis: The Impact of Environment and Genes—A Population Based Twin Study
PLoS ONE ·Anders Jørgen Svendsen, Kirsten Ohm Kyvik, Gunnar Houen, Peter Junker, Kaare Christensen, Lene Christiansen, Christian Nielsen, Axel Skytthe, Jacob Hjelmborg
201365
16
Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP
Annals of the Rheumatic Diseases ·Merete Lund Hetland, Mikkel Østergaard, Bo Ejbjerg, Søren Jacobsen, Kristian Stengaard‐Pedersen, Peter Junker, Tine Lottenburger, Ib Tønder Hansen, Lis Smedegaard Andersen, Ulrik Tarp, Anders Jørgen Svendsen, (unknown), Henrik Skjødt, Torkell Ellingsen, Hanne Lindegaard, Jan Pødenphant, Kim Hørslev‐Petersen
201265
17
On the heritability of psoriatic arthritis. Disease concordance among monozygotic and dizygotic twins
Annals of the Rheumatic Diseases ·Ole Birger Pedersen, Anders Jørgen Svendsen, L. Ejstrup, Axel Skytthe, Peter Junker
200860
18
Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis
The Pharmacogenomics Journal ·S. B. Krintel, Christian Dehlendorff, Merete Lund Hetland, (unknown), Klaus K. Andersen, Peter Junker, Jan Pødenphant, Torkell Ellingsen, Palle Ahlquist, Hanne Lindegaard, Asta Linauskas, A. Schlemmer, Mette Yde Dam, I. Hansen, Hans Christian Horn, Anne Jørgensen, Johnny Raun, Christian Gytz Ammitzbøll, Mikkel Østergaard, Kristian Stengaard‐Pedersen, Julia S. Johansen
201555
19
FIBRONECTIN IN EXPERIMENTAL GRANULATION TISSUE
Acta Pathologica Microbiologica Scandinavica Series A Pathology ·Berit Hølund, Inge Clemmensen, Peter Junker, Hans Lyon
198254
20
Low-cost, low-field dedicated extremity magnetic resonance imaging in early rheumatoid arthritis: a 1-year follow-up study
Annals of the Rheumatic Diseases ·Hanne Lindegaard, J. Vallø, (unknown), Peter Junker, Mikkel Østergaard
200653

About Peter Junker

Peter Junker is a scholar working on Rheumatology, Immunology, Hematology, Molecular Biology and Epidemiology, having authored 183 papers that have together received 4.1k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (47 papers), Systemic Lupus Erythematosus Research (27 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Cell Adhesion Molecules Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Spondyloarthritis Studies and Treatments (9 papers), Galectins and Cancer Biology (9 papers) and Vitamin D Research Studies (7 papers). The work is most often cited by research in Rheumatology (1.8k citations), Immunology (1.1k citations), Hematology (417 citations), Genetics (252 citations) and Immunology and Allergy (130 citations). Peter Junker has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include Anne Voss, Anders Jørgen Svendsen, Mikkel Østergaard, Merete Lund Hetland, Kim Hørslev‐Petersen, Hanne Lindegaard, Kristian Stengaard‐Pedersen, Helle Laustrup, I. Lorenzen and Torkell Ellingsen. Their work appears in journals such as Annals of the Rheumatic Diseases, Scandinavian Journal of Rheumatology, Arthritis Research & Therapy, Lupus and The Journal of Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas BarnetcheBreakdown of academic impact, for papers by Carrie WagnerBreakdown of academic impact, for papers by Shigeto TohmaBreakdown of academic impact, for papers by John J. CushBreakdown of academic impact, for papers by Dae‐Hyun YooBreakdown of academic impact, for papers by L B van de PutteBreakdown of academic impact, for papers by Koichiro OhmuraBreakdown of academic impact, for papers by Gurtej S. CheemaBreakdown of academic impact, for papers by Gabriella LakosBreakdown of academic impact, for papers by Corinne Miceli‐Richard